The science
The premise — that pigment-modulating actives are best delivered at the moment of UV exposure — rests on the biology of UV-induced melanogenesis, in which irradiated keratinocytes release signals including plasmin-activated cytokines and melanocyte-stimulating hormone that drive melanocytes to produce and export pigment over the following hours. Tranexamic acid, a synthetic lysine analogue, inhibits plasminogen activation and thereby damps this keratinocyte-to-melanocyte signalling; the topical evidence is smaller than the oral melasma literature but growing, and a 2017 systematic review and meta-analysis by Kim and colleagues in Acta Dermato-Venereologica of tranexamic acid for melasma across oral, topical and injected routes found consistent reductions in melasma severity scores, with topical preparations typically studied at 2 to 5%. The 1% here is below most studied topical concentrations, and the leave-on sunscreen format offers sustained contact that partly compensates. Niacinamide's effect on melanosome transfer was established by Hakozaki and colleagues in the British Journal of Dermatology in 2002, in vitro and in two clinical trials at 2 to 5%, which places the declared 2% at the floor of the evidenced range. Phenylethyl resorcinol is a synthetic tyrosinase inhibitor structurally related to compounds in Scots pine bark; supplier and small clinical data show potent in-vitro tyrosinase inhibition and modest depigmenting activity at 0.3 to 1%, and it is a recognised contact sensitiser at higher levels, which is the reason for the low declared dose.
The filter system is standard monograph chemistry — avobenzone for UVA, photostabilised by octocrylene, with homosalate and octisalate for UVB — reaching SPF 30 and broad-spectrum status. The FDA's 2019 proposed rule requested additional safety data on all four organic filters, and avobenzone and octocrylene carry the highest rates of sunscreen contact and photocontact allergy among common filters. The formula's iron oxide is present as a colour pigment rather than at the concentrations needed to attenuate visible light, which controlled studies have shown contributes to melasma and which tinted iron-oxide sunscreens at 3% or more can block.
The brand's clinical study — 44 participants, Fitzpatrick II to V, 12 weeks, reporting 24% reductions in visible discoloration and 24% gains in radiance — is more transparent than most cosmetic sunscreen claims about its size and population, but it is unpublished, company-run, and has no plain-sunscreen control arm, so it cannot separate the actives' contribution from the well-documented effect of daily photoprotection alone on pigmentation. The fragrance components — citral, geraniol, limonene, linalool, citronellol — are among the allergens the European cosmetic framework requires to be declared, and their inclusion in a product aimed at pigment-prone skin sits awkwardly with the evidence that irritation itself provokes post-inflammatory hyperpigmentation in darker skin types.
References 2 ShowHide
- The effect of niacinamide on reducing cutaneous pigmentation and suppression of melanosome transfer — British Journal of Dermatology (2002)
- Efficacy and safety of tranexamic acid in melasma: a meta-analysis and systematic review — Acta Dermato-Venereologica (2017)